A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Overall summary of adverse events (treated set).

药物不良反应监测

临床试验安全性分析

aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino

NIAID Data Ecosystem20

Safety outcomes in the patients who received an injection of the investigational product.

临床试验安全性评估

药物不良反应监测

Safety outcomes in the patients who received an injection of the investigational product.

Figshare2019-12-10 更新50

Dataset for: OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder”

精神药理学

精准医学

This dataset contains the anonymized individual-level data used in the study "OXTR rs2254298 polymorphism influences escitalopram response in Generalized Anxiety Disorder: a sex-specific role for oxyt

DataCite Commons2025-10-03 更新20

Pseudophaeochromocytoma syndrome associated with clozapine

资源简介：

相关数据集